Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood

Roy Lardenoije, Janou A. Y. Roubroeks, Ehsan Pishva, Markus Leber, Holger Wagner, Artemis Iatrou, Adam R. Smith, Rebecca G. Smith, Lars M. T. Eijssen, Luca Kleineidam, Amit Kawalia, Per Hoffmann, Tobias Luck, Steffi Riedel-Heller, Frank Jessen, Wolfgang Maier, Michael Wagner, Rene Hurlemann, Gunter Kenis, Muhammad AliAntonio del Sol, Diego Mastroeni, Elaine Delvaux, Paul D. Coleman, Jonathan Mill, Bart P. F. Rutten, Katie Lunnon, Alfredo Ramirez, Daniel L. A. van den Hove*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number164
Number of pages15
JournalClinical epigenetics
Volume11
Issue number1
DOIs
Publication statusPublished - 27 Nov 2019

Keywords

  • Alzheimer's disease
  • Epigenetics
  • DNA methylation
  • DNA hydroxymethylation
  • Brain
  • Middle temporal gyrus
  • Blood
  • GENOME-WIDE ASSOCIATION
  • DNA METHYLATION
  • GLOBAL CHANGES
  • 5-HYDROXYMETHYLCYTOSINE
  • OXYTOCIN
  • DEMENTIA
  • HYDROXYMETHYLATION
  • HEALTH
  • ROLES
  • COGNITION

Cite this

Lardenoije, R., Roubroeks, J. A. Y., Pishva, E., Leber, M., Wagner, H., Iatrou, A., Smith, A. R., Smith, R. G., Eijssen, L. M. T., Kleineidam, L., Kawalia, A., Hoffmann, P., Luck, T., Riedel-Heller, S., Jessen, F., Maier, W., Wagner, M., Hurlemann, R., Kenis, G., ... van den Hove, D. L. A. (2019). Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood. Clinical epigenetics, 11(1), [164]. https://doi.org/10.1186/s13148-019-0755-5